New Q&As on Chapter 4 and 5 of the EU-GDP Guidelines
Recommendation
9 September 2025
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Register now for ECA's GMP Newsletter
On the GDP Association Website a section was set up a while ago dealing with frequently asked questions (FAQs). Now a set of new FAQs has been published on Chapter 4 (Documentation) and Chapter 5 (Operations).
For example, the following questions are discussed:
- Who authors documents? Who needs to approve them?
- In which language should documents be written?
- Is it allowed to print procedures from an electronic system?
- How can I check if a supplier has an appropriate legal authorisation?
- Besides temperature, are there other environmental factors which might harm medicinal products?
- Why do I need to qualify customers?
Answers to these and other questions are provided in the new FAQs on GDP.
Related GMP News
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms
10.06.2025Questions and Answers from the ECA Webinar "GDP Update 2025" - Part 3
10.06.2025Meet the GDPA Board Members at the GDP Forum in Barcelona
10.06.2025Swissmedic Technical Interpretation: What Counts as a Major Change in GDP?
10.06.2025MHRA informes about Validity Date of UK issued GDP Certificates